Novel Anticoagulants May Not Boost Intraocular Bleeding Risk

Compared to other antithrombotic drugs, novel oral anticoagulants (NOACs) do not pose an extra risk of substantial intraocular bleeding, according to Portuguese researchers.
Reuters Health Information

Full Story →